Who is sponsoring NCT07535736?

NCT07535736 is sponsored by Assiut University.

What drugs are being tested in NCT07535736?

Interventions in NCT07535736: Anti-Epileptic.

What condition does NCT07535736 study?

NCT07535736 studies Antiepileptic Efficacy and Safety, Brain Injuries.

Is NCT07535736 still recruiting?

NCT07535736 is currently not yet recruiting. Last updated 17 April 2026.

Last reviewed 2026-04-17 · How we verify

NCT07535736

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

Not yet recruiting Last updated 17 April 2026

What this trial tests

trial testing Anti-Epileptic in Antiepileptic Efficacy and Safety in 70 participants. Not yet recruiting.

Timeline

1 May 2026

Primary endpoint
30 May 2027

30 June 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 May 2026
Primary completion	30 May 2027
Estimated completion	30 June 2027

Drugs / interventions tested

Anti-Epileptic

Conditions studied

Antiepileptic Efficacy and Safety — all drugs for Antiepileptic Efficacy and Safety →
Brain Injuries — all drugs for Brain Injuries →

Sponsor

Assiut University

Who can join

Adults 18 to 75, any sex, with Antiepileptic Efficacy and Safety or Brain Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effectiveness and safety of anti-epileptic drugs in the prevention of early and late post-traumatic seizures among patients with trauma brain injury

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07535736 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07535736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing